Triana Biomedicines: Funding, Investors & Team (Oct 2026)
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.
Triana Biomedicines has raised $120M across 1 funding round on record, the most recent a Series B of $120M announced in Dec 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Triana Biomedicines Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Triana Biomedicines Funding Rounds
Triana Biomedicines Founders and Leadership Team
No contact details are on record for this team yet.
Triana Biomedicines Funding Compared to Other Biotechnology Startups
Triana Biomedicines' latest round of $120M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Triana Biomedicines in Biotechnology and Lexington
Companies Similar to Triana Biomedicines
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Triana Biomedicines Funding FAQs
What does Triana Biomedicines do?
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.
How much funding has Triana Biomedicines raised?
Triana Biomedicines has raised $120M across 1 round on record. The most recent is a Series B of $120M announced in Dec 2025.
When did Triana Biomedicines last raise funding?
Triana Biomedicines' most recent funding round on record is a Series B of $120M, announced in Dec 2025.
Who founded Triana Biomedicines?
FundedIQ lists Milind Deshpande (Founder) at Triana Biomedicines.
Where is Triana Biomedicines headquartered?
Triana Biomedicines is based in Lexington, Massachusetts, United States.
How many employees does Triana Biomedicines have?
Triana Biomedicines is in the 51-100 employee band.
How does Triana Biomedicines' funding compare to other Biotechnology startups?
Triana Biomedicines' latest round of $120M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Triana Biomedicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Triana Biomedicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.